FRIDAY, Oct. 25, 2024 — Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA Dermatology.
Amy S. Paller…Original Article
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
FRIDAY, Oct. 25, 2024 — Long-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA Dermatology.
Amy S. Paller…
